From scant data, the armamentarium is expanding, with an increasing evidence base ...

For many decades since its initial characterization by Sir William Osler in 1888, hereditary angioedema (HAE) attacks could only be managed symptomatically and there was no way to prevent occurrence ...

Angioedema is deep tissue swelling that may occur due to various health conditions. Treating angioedema swelling depends on the cause. Angioedema may be acute or chronic, and acute symptoms may last ...

BioCryst Pharmaceuticals, Inc. announced promising new data regarding their oral prophylactic treatment, ORLADEYO (berotralstat), for hereditary angioedema (HAE) during the 14th C1-Inhibitor ...

Please provide your email address to receive an email when new articles are posted on . Patient Global Impression of Severity scores showed greater reduction from baseline compared with placebo. Mean ...

Idiopathic angioedema is a skin reaction that causes swelling in tissues under the skin. The cause is unknown, but stress, infections, and exposure to heat or allergens may trigger it. Various ...

Angiotensin converting enzyme (ACE) inhibitors, a type of blood pressure medication, are usually well tolerated, but one of their rare side effects is angioedema. Angiotensin converting enzyme (ACE) ...

Angioedema is the swelling under the skin caused by allergies, infections, or genetics. Angioedema can cause breathing problems and might need emergency treatment if it affects the throat. Treatment ...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

Data demonstrated rapid symptom relief and attack resolution regardless of attack severity, location, age, or use of long-term prophylaxis, and well-established safety profile “As the first orally ...

Its not always possible to know when a hereditary angioedema (HAE) attack will strike. But specific triggers account for ...